|
Janssen says Tremfya beat Cosentyx
|
Wed-12-12-2018, 20:16 PM
(Wed-12-12-2018, 18:54 PM)Caroline Wrote: And Tremfya is not the first IL-23 inhibitor, that would be Stelara. Which was also Janssen so they have a head start, but I find it encouraging as Stelara did help me for a long time and is probably my next step. And as for which is the best Interleukin target, I don't understand enough about them to know which is the best. All I want is something that works for me. |
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Effectiveness of Tremfya in patients with facial and/or genital psoriasis | Fred | 0 | 845 |
Fri-28-06-2024, 13:10 PM Last Post: Fred |
|
|
Tremfya and sexual impairment | Fred | 7 | 4,003 |
Thu-20-06-2024, 03:12 AM Last Post: mataribot |
|
|
Tremfya and serum protein levels | Fred | 0 | 849 |
Thu-09-05-2024, 19:48 PM Last Post: Fred |
|
|
Polymorphisms associated with Cosentyx | Fred | 6 | 2,963 |
Sun-07-01-2024, 11:01 AM Last Post: Caroline |
|
|
Persistence and effectiveness of Tremfya in Spanish psoriasis patients | Fred | 0 | 1,702 |
Sat-12-08-2023, 13:53 PM Last Post: Fred |
Health Boards
